Mid-Atlantic BioTherapeutics

Mid-Atlantic BioTherapeutics and Accelero Biostructures Join Forces to Tackle Neurological Disorders with Innovative USP30 Inhibitors

DOYLESTOWN, PA — Mid-Atlantic BioTherapeutics (MABT) and Accelero Biostructures have entered a research collaboration aimed at developing novel USP30 inhibitors. These inhibitors target neurological disorders such as Alzheimer’s and Parkinson’s Diseases, …

Mid-Atlantic BioTherapeutics and Accelero Biostructures Join Forces to Tackle Neurological Disorders with Innovative USP30 Inhibitors Read More

sfa therapeutics

SFA Therapeutics Appoints Dr. Ananda Gubbi as Director of Biostatistics to Enhance Drug Development

JENKINTOWN, PA — SFA Therapeutics, Inc. recently appointed Dr. Ananda Gubbi, Ph.D., as Director of Biostatistics, a strategic move to bolster the company’s drug development capabilities. With over 25 years of …

SFA Therapeutics Appoints Dr. Ananda Gubbi as Director of Biostatistics to Enhance Drug Development Read More